Stock Analiz

PROCEPT BioRobotics Corp (PRCT) financials: revenue, earnings and cash flow

Fiscal 2020–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

PROCEPT BioRobotics’s revenue went from $8M in fiscal 2020 to $308M in fiscal 2025, growth of about 109.0% a year.

Net income in fiscal 2025 was -$96M, a net margin of -31.0%; the best year in this period was 2020 with -$53M.

Over the twelve months to September 30, 2026, revenue was $352M and net income -$115M.

Free cash flow was -$58M in fiscal 2025 and positive in 0 of the 6 years shown.

The diluted share count rose 1416% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2020: $8M20202021: $34M20212022: $75M20222023: $136M20232024: $224M20242025: $308M2025$308M
Net income
2020: -$53M20202021: -$60M20212022: -$87M20222023: -$106M20232024: -$91M20242025: -$96M2025-$96M
Free cash flow
2020: -$49M20202021: -$58M20212022: -$83M20222023: -$133M20232024: -$104M20242025: -$58M2025-$58M
EPS (diluted)
2020: $-14.4720202021: $-3.6320212022: $-1.9620222023: $-2.2420232024: $-1.7520242025: $-1.722025$-1.72

Income statement

Fiscal yearTTM202520242023202220212020
Revenue$352M$308M$224M$136M$75M$34M$8M
Gross profit$228M$196M$137M$71M$37M$16M-$1M
Operating income-$118M-$104M-$97M-$109M-$81M-$54M-$48M
Net income-$115M-$96M-$91M-$106M-$87M-$60M-$53M
EPS (diluted)$-2.02$-1.72$-1.75$-2.24$-1.96$-3.63$-14.47
R&D$81M$71M$62M$48M$29M$19M$16M
Revenue growth—+37.2%+64.8%+81.5%+117.6%+346.7%—

Cash flow

Fiscal yearTTM202520242023202220212020
Operating cash flow-$77M-$49M-$99M-$108M-$80M-$57M-$48M
Capital spending-$8M-$9M-$4M-$25M-$3M-$592000-$233000
Free cash flow-$85M-$58M-$104M-$133M-$83M-$58M-$49M
Dividends paid—$0$0$0$0$0$0
Buybacks———————
Stock-based pay$54M$48M$32M$19M$10M$4M$2M

Balance sheet

Fiscal yearTTM202520242023202220212020
Cash—$287M$334M$257M$222M$304M$100M
Debt—$78M$80M$79M$77M$54M$55M
Equity—$366M$402M$281M$197M$267M-$183M
Total assets—$508M$534M$405M$309M$337M$126M
Shares (diluted)57M56M52M47M44M16M4M

Margins and returns

Fiscal yearTTM202520242023202220212020
Gross margin64.7%63.7%61.1%52.2%49.4%46.0%-16.3%
Operating margin-33.6%-33.7%-43.0%-80.2%-107.6%-157.1%-619.4%
Net margin-32.6%-31.0%-40.7%-77.8%-116.2%-173.6%-687.0%
FCF margin-24.1%-18.9%-46.2%-97.8%-110.7%-168.0%-629.5%
ROIC—-18.5%-15.8%-24.0%-23.2%-13.3%—
ROE—-26.1%-22.7%-37.7%-44.2%-22.4%29.0%

Frequently asked questions

What is PROCEPT BioRobotics’s annual revenue?

$308M in fiscal 2025 and $352M over the twelve months to September 30, 2026.

How much profit does PROCEPT BioRobotics make?

Net income was -$96M in fiscal 2025 (net margin -31.0%).

Is PROCEPT BioRobotics’s revenue growing?

Yes: revenue rose 37.2% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.